Paper2536062
Signaling through T lymphocyte surface proteins, TCR/CD3 and CD28, activates the HIV-1 long terminal repeat.
Tong-Starkesen SE and 2 others. J Immunol, 1989. Cited by 157 papers, by iCite.
Cite this record
ConductScience Library. Signaling through T lymphocyte surface proteins, TCR/CD3 and CD28, activates the HIV-1 long terminal repeat. Papers, record 2536062. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2536062
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antigens, Differentiation, T-Lymphocyte | Major topic |
| Gene Expression Regulation | Major topic |
| HIV | Major topic |
| Receptors, Antigen, T-Cell | Major topic |
| Repetitive Sequences, Nucleic Acid | Major topic |
| Signal Transduction | Major topic |
| T-Lymphocytes | Major topic |
| Animals | |
| Antibodies, Monoclonal | |
| CD28 Antigens | |
| Cyclosporins | |
| DNA-Binding Proteins | |
| Genes, Viral | |
| Humans | |
| Membrane Proteins | |
| Mice | |
| Nuclear Proteins | |
| Phytohemagglutinins | |
| Tetradecanoylphorbol Acetate |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| A125609 | PHS HHS | United States | PubMed |
Source PubMed
Cited by69
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 157 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41325410 | Lymphoid B cells upregulate HIV-1 ex vivo and are linked to its expression in vivo. | PLoS Pathog | 2025 | https://conductscience.org/library/papers/41325410 | PubMed |
| 38765786 | Defining the Effects of PKC Modulator HIV Latency-Reversing Agents on Natural Killer Cells. | Pathog Immun | 2024 | https://conductscience.org/library/papers/38765786 | PubMed |
| 35891551 | Off-Target Effect of Activation of NF-κB by HIV Latency Reversal Agents on Transposable Elements Expression. | Viruses | 2022 | https://conductscience.org/library/papers/35891551 | PubMed |
| 35794316 | HIV cure strategies: which ones are appropriate for Africa? | Cell Mol Life Sci | 2022 | https://conductscience.org/library/papers/35794316 | PubMed |
| 33465149 | Extensive proteomic and transcriptomic changes quench the TCR/CD3 activation signal of latently HIV-1 infected T cells. | PLoS Pathog | 2021 | https://conductscience.org/library/papers/33465149 | PubMed |
| 32784426 | Efficient Non-Epigenetic Activation of HIV Latency through the T-Cell Receptor Signalosome. | Viruses | 2020 | https://conductscience.org/library/papers/32784426 | PubMed |
| 31999647 | Differences in inducibility of the latent HIV reservoir in perinatal and adult infection. | JCI Insight | 2020 | https://conductscience.org/library/papers/31999647 | PubMed |
| 31988180 | Combination Immune Checkpoint Blockade to Reverse HIV Latency. | J Immunol | 2020 | https://conductscience.org/library/papers/31988180 | PubMed |
| 28122985 | BCA2/Rabring7 Interferes with HIV-1 Proviral Transcription by Enhancing the SUMOylation of IκBα. | J Virol | 2017 | https://conductscience.org/library/papers/28122985 | PubMed |
| 26425694 | A Novel Assay to Measure the Magnitude of the Inducible Viral Reservoir in HIV-infected Individuals. | EBioMedicine | 2015 | https://conductscience.org/library/papers/26425694 | PubMed |
| 25421889 | HIV eradication: combinatorial approaches to activate latent viruses. | Viruses | 2014 | https://conductscience.org/library/papers/25421889 | PubMed |
| 25287643 | Targeting NF-κB signaling with protein kinase C agonists as an emerging strategy for combating HIV latency. | AIDS Res Hum Retroviruses | 2015 | https://conductscience.org/library/papers/25287643 | PubMed |
| 22345467 | Kinase control prevents HIV-1 reactivation in spite of high levels of induced NF-κB activity. | J Virol | 2012 | https://conductscience.org/library/papers/22345467 | PubMed |
| 19561536 | Genetic modification of T cells with IL-21 enhances antigen presentation and generation of central memory tumor-specific cytotoxic T-lymphocytes. | J Immunother | 2009 | https://conductscience.org/library/papers/19561536 | PubMed |
| 17341462 | Tat competes with HEXIM1 to increase the active pool of P-TEFb for HIV-1 transcription. | Nucleic Acids Res | 2007 | https://conductscience.org/library/papers/17341462 | PubMed |
| 15767432 | Tetraspanin CD81 provides a costimulatory signal resulting in increased human immunodeficiency virus type 1 gene expression in primary CD4+ T lymphocytes through NF-kappaB, NFAT, and AP-1 transduction pathways. | J Virol | 2005 | https://conductscience.org/library/papers/15767432 | PubMed |
| 15163761 | Engagement of ICAM-3 provides a costimulatory signal for human immunodeficiency virus type 1 replication in both activated and quiescent CD4+ T lymphocytes: implications for virus pathogenesis. | J Virol | 2004 | https://conductscience.org/library/papers/15163761 | PubMed |
| 14762397 | Reciprocal regulation of the nuclear factor of activated T cells and HIV-1. | Genes Immun | 2004 | https://conductscience.org/library/papers/14762397 | PubMed |
| 14674708 | Curcumin inhibits ultraviolet light induced human immunodeficiency virus gene expression. | Mol Cell Biochem | 2003 | https://conductscience.org/library/papers/14674708 | PubMed |
| 10602461 | Activators and target genes of Rel/NF-kappaB transcription factors. | Oncogene | 1999 | https://conductscience.org/library/papers/10602461 | PubMed |
Genes6
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD28 | 940 | PubTator's text mining | https://conductscience.org/library/genes/940 | NCBI Gene |
| IL2 | 3558 | PubTator's text mining | https://conductscience.org/library/genes/3558 | NCBI Gene |
| IL2RA | 3559 | PubTator's text mining | https://conductscience.org/library/genes/3559 | NCBI Gene |
| NFKB1 | 4790 | PubTator's text mining | https://conductscience.org/library/genes/4790 | NCBI Gene |
| PRRT2 | 112476 | PubTator's text mining | https://conductscience.org/library/genes/112476 | NCBI Gene |
| TRBV20OR9-2 | 6962 | PubTator's text mining | https://conductscience.org/library/genes/6962 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2536062
GET https://conductscience.org/api/papers/v1/2536062/cited_by?page=2